Under this approach, drugs are conditionally approved and marketed, with the revenue generated following the conditional approval covering the costly trial for proving efficacy. Such a scheme facilitates lower drug pricing, while overcoming the effect of Eroom’s law on investment in treatments for many diseases.
社会也必须共同承担药品开发的成本。全球监管机构可以效仿英国的先例，实施适应性许可制度。根据这一办法，药品被有条件批准和上市，用有条件批准后所获得的收入覆盖昂贵的药效验证试验。这一制度有助于降低药价，同时克服许多疾病治疗投资上逆摩尔定律。